Randox Launches Adiponectin Assay for Metabolic Risk Assessment
The Randox adiponectin assay is a liquid, ready-to-use reagent that can be used on a wide range of clinical chemistry analyzers.
Read MorePosted by | Jan 9, 2020 | Cardiovascular, Clinical Chemistry Analyzers |
The Randox adiponectin assay is a liquid, ready-to-use reagent that can be used on a wide range of clinical chemistry analyzers.
Read MoreCirculating tumor cell analysis, using the Ikoniscope platform to find extremely rare cells, has great potential to transform the cancer diagnostic landscape.
Read MorePosted by Steve Halasey | Dec 20, 2019 | Culture Media, Molecular Diagnostics, Sepsis, Software |
Rapid molecular diagnostics contribute to improved patient outcomes.
Read MorePosted by | Dec 5, 2019 | Prostate |
Unmatched resources will enable researchers to identify distinctive disease mechanisms in small patient subgroups, supporting the development of custom therapeutic approaches.
Read MorePosted by | Dec 3, 2019 | Research |
A partnership with Illumina will enable physicians to order clinical immunodiagnostic tests that can be performed in local laboratories.
Read More